Nationwide Fund Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-181,165	Closed	-$25.4M	–	2561
2017 Q3	$25.4M	Sell	181,165 -8,655	-5%	-$1.18M	0.1%	221
2017 Q2	$23.1M	Sell	189,820 -52,278	-22%	-$6.08M	0.09%	261
2017 Q1	$29.4M	Buy	242,098 +14,819	+7%	+$1.91M	0.12%	179
2016 Q4	$27.8M	Buy	227,279 +132,235	+139%	+$16.2M	0.12%	188
2016 Q3	$11.6M	Sell	95,044 -1,633	-2%	-$210K	0.05%	545
2016 Q2	$11.3M	Sell	96,677 -66,416	-41%	-$9.42M	0.05%	528
2016 Q1	$23.7M	Sell	163,093 -18,790	-10%	-$2.76M	0.1%	224
2015 Q4	$34.7M	Sell	181,883 -115,215	-39%	-$20.1M	0.15%	139
2015 Q3	$46.5M	Sell	297,098 -8,984	-3%	-$1.64M	0.21%	81
2015 Q2	$55.3M	Buy	306,082 +49,621	+19%	+$8.56M	0.23%	74
2015 Q1	$44.4M	Sell	256,461 -22,936	-8%	-$4.15M	0.18%	107
2014 Q4	$51.7M	Sell	279,397 -51	-0%	-$9.45K	0.22%	75
2014 Q3	$46.3M	Sell	279,448 -32,493	-10%	-$5.34M	0.2%	92
2014 Q2	$48.7M	Buy	+311,941	New	+$49.3M	0.2%	94
2014 Q1	–	Sell	-327,476	Closed	-$43.6M	–	3231
2013 Q4	$43.6M	Buy	327,476 +12,987	+4%	+$1.56M	0.18%	108
2013 Q3	$36.5M	Sell	314,489 -39,258	-11%	-$4.31M	0.16%	121
2013 Q2	$32.6M	Buy	+353,747	New	+$34.1M	0.17%	104